GLP-1 & Metabolic

Tirzepatide

SKU NA-004CAS 2023788-19-2MW 4813.5
99.4% HPLCThird-party testedRUO · Research use only
RUOThis product is sold for laboratory research use only. It is not a drug or supplement and is not for human or veterinary consumption, diagnostic or therapeutic use.

Price range: $34.99 through $101.99

HPLC verifiedPurity confirmed per lot
COA includedLot-specific certificate
Cold-chainShipped 2-8°C with packs
Lot traceableDocumented to dispatch
Description

Tirzepatide is a dual GIP and GLP-1 receptor agonist peptide supplied lyophilized for laboratory research. Identity is confirmed by LC-MS and purity by RP-HPLC; a Certificate of Analysis accompanies every lot.

Specifications
CompoundTirzepatide
ClassificationDual GIP/GLP-1 receptor agonist
CAS number2023788-19-2
Molecular formulaC225H348N48O68
Molecular weight4813.5 g/mol
Purity99.4% by RP-HPLC (area %)
Physical formLyophilized powder
AppearanceWhite to off-white solid
ReconstitutionBacteriostatic water, 0.6% acetic acid
Lab documentation

Each production lot is released against an analytical specification and ships with the corresponding Certificate of Analysis.

Certificate of AnalysisLot TZP-2406-A
MethodRP-HPLC / UV 214 nm
Purity (area %)99.4%
IdentityESI-MS confirmed
AppearanceWhite to off-white solid
Storage & handling

Storage. Store lyophilized material at -20°C protected from light and moisture for long-term stability. After reconstitution, keep at 2-8°C and use within the documented in-use window.

Handling. Allow sealed vials to equilibrate to room temperature before opening to limit condensation. Reconstitute with the listed diluent using standard aseptic laboratory technique. Avoid repeated freeze-thaw cycles.

Safety. Handle as a laboratory research chemical. Wear appropriate PPE and follow your institution's chemical-handling and waste-disposal procedures.

Shipping

Dispatch. In-stock orders are processed on business days and shipped with temperature-controlled packaging and gel packs to preserve material integrity in transit.

Tracking. A tracking reference is issued at dispatch. Lab accounts can consolidate shipments and arrange standing orders.

Eligibility. Orders are accepted from researchers, resellers and institutions for laboratory research use only.

Selected research

Literature referencing this compound.

Publications relevant to this molecule, provided for research reference. Inclusion does not imply an approved use or any claim about the products sold here.

Phase 3 RCT
N Engl J Med. 2022;387(3):205–216
Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)
Jastreboff AM, Aronne LJ, Ahmad NN, et al.
Phase 3 RCT
N Engl J Med. 2025;392(10):958–971
Tirzepatide for Obesity Treatment and Diabetes Prevention (3-year SURMOUNT-1)
Jastreboff AM, le Roux CW, Stefanski A, et al.
Phase 3 RCT
N Engl J Med. 2021;385(6):503–515
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2)
Frías JP, Davies MJ, Rosenstock J, et al.